Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteogenomic characterization of MiT family translocation renal cell carcinoma. | Nat Commun | 2022 | 36470859 | PubTator, text mining | PubMed |
| Characterization of a proteomic profile associated with organ dysfunction and mortality of sepsis and septic shock. | PLoS One | 2022 | 36459524 | PubTator, text mining | PubMed |
| Neck Swelling in a Critically Ill Patient With COVID-19-Related Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation: Consider the Differential. | Cureus | 2022 | 36457626 | PubTator, text mining | PubMed |
| How physicians approach hereditary angioedema: a single center study. | Asia Pac Allergy | 2022 | 36452014 | PubTator, text mining | PubMed |
| Classical Ehlers-Danlos syndrome with severe kyphoscoliosis due to a novel pathogenic variant of COL5A2. | Clin Case Rep | 2022 | 36447672 | PubTator, text mining | PubMed |
| C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment. | Sci Rep | 2022 | 36443341 | PubTator, text mining | PubMed |
| Non-alcoholic fatty liver disease and liver secretome. | Arch Pharm Res | 2022 | 36441472 | PubTator, text mining | PubMed |
| A Rapid and Sensitive Aptamer-Based Biosensor for Amnesic Shellfish Toxin Domoic Acid. | Bioengineering (Basel) | 2022 | 36421085 | PubTator, text mining | PubMed |
| Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs. | Front Immunol | 2022 | 36420270 | PubTator, text mining | PubMed |
| MS-proteomics provides insight into the host responses towards alginate microspheres. | Mater Today Bio | 2022 | 36420052 | PubTator, text mining | PubMed |
| A tick C1q protein alters infectivity of the Lyme disease agent by modulating interferon γ. | Cell Rep | 2022 | 36417869 | PubTator, text mining | PubMed |
| Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | 36415513 | PubTator, text mining | PubMed |
| Fatigue-Induced Surface Modification of Zr-Based Metallic Glass under Environmental Conditions. | ACS Omega | 2022 | 36406584 | PubTator, text mining | PubMed |
| A rare association between factor H deficiency and lupus: Case report and experimental treatment with curcumin. | Front Pediatr | 2022 | 36405845 | PubTator, text mining | PubMed |
| Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment. | Front Immunol | 2022 | 36405681 | PubTator, text mining | PubMed |
| Bullous pemphigoid-What do we know about the most recent therapies? | Front Med (Lausanne) | 2022 | 36405625 | PubTator, text mining | PubMed |
| Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases. | J Neuroinflammation | 2022 | 36397116 | PubTator, text mining | PubMed |
| Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children. | Sci Rep | 2022 | 36396679 | PubTator, text mining | PubMed |
| Complement C5 is a novel biomarker for liver metastasis of colorectal cancer. | J Gastrointest Oncol | 2022 | 36388659 | PubTator, text mining | PubMed |
| ALASCA: An R package for longitudinal and cross-sectional analysis of multivariate data by ASCA-based methods. | Front Mol Biosci | 2022 | 36387276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=28